FHI-B:CA:TSX-CI Health Care Giants Covered Call ETF (CAD)

ETF | Others |

Last Closing

CAD 12.44

Change

-0.10 (-0.80)%

Market Cap

CAD 0.05B

Volume

200.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.20 (+0.76%)

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

-0.16 (-0.47%)

CAD 6.03B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.57B
PHYS-U:CA Sprott Physical Gold Trust

+0.11 (+0.54%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.56 (-1.49%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.29 (-0.64%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.34 (+1.40%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.09 (+0.90%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.06 (-0.27%)

CAD 2.78B

ETFs Containing FHI-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.57% 48% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.57% 48% F 44% F
Trailing 12 Months  
Capital Gain 1.88% 20% F 26% F
Dividend Return 3.47% 62% D 48% F
Total Return 5.36% 22% F 26% F
Trailing 5 Years  
Capital Gain 9.60% 44% F 47% F
Dividend Return 33.83% 88% B+ 88% B+
Total Return 43.43% 61% D- 57% F
Average Annual (5 Year Horizon)  
Capital Gain 4.00% 55% F 47% F
Dividend Return 4.47% 56% F 43% F
Total Return 0.47% 74% C 30% F
Risk Return Profile  
Volatility (Standard Deviation) 5.04% 82% B 92% A
Risk Adjusted Return 88.69% 94% A 91% A-
Market Capitalization 0.05B 43% F 23% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.